DOI:
10.1055/s-00029030
Journal of Pediatric Neurology
LinksClose Window
References
Darras BT, Farrar MA, Mercuri E. et al.
An integrated safety analysis of infants and children with symptomatic spinal muscular atrophy (SMA) treated with nusinersen in seven clinical trials.
CNS Drugs 2019;
33 (09) 919-932
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.